As per the latest report, Global Muscle Hypertonia Treatment Market, by Drug Type (Baclofen, Diazepam, Dantrolene), By Prognosis (Mild Condition, Moderate Condition, Severe Condition) and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) by Meridian Market Consultants, the growing incidence of muscle hypertonia and improving treatment-seeking rates are the factors attributed to growth in global muscle hypertonia treatment market. MMC predicts that the market will grow at a significant CAGR for the period between 2019 and 2027.
Meridian Market Consultants (MMC) Study identifies that, increasing awareness about muscle hypertonia is leading to increasing treatment seeking rates in countries such as U.S. Treatment of muscle hypertonia includes physical therapy and pharmacological therapy. Aim of physical therapy is to inhibit excessive muscle tone. Physiotherapy can control the muscle hypertonia through the use of stretching. Local anesthetics can decrease reflective activity. Shcok wave therapy is being used to treat muscle hypertonia since 1997. Pharmacological therapy involves treatment with muscle relaxing drugs such as baclofen, diazepam, and dantrolene. Baclofen is generally the drug of choice for spinal cord types of spasticity, while sodium dantrolene is the only agent which acts directly on muscle tissue. All of these drugs can be taken by mouth, but baclofen may also be injected directly into the cerebrospinal fluid through an implanted pump. Botulinum toxin is often used to relieve hypertonia in a specific area of the body.
To know the latest insights, qualitative data, trends, quantitative data, and more related to Global Muscle Hypertonia Treatment Market, visit: https://www.meridianmarketconsultants.com/global-muscle-hypertonia-treatment-market
MMC Study identifies some of the key participating players in Muscle Hypertonia Treatment market globally are Apotex Corporation, Sanis Health Inc., Sterimax Inc., Piramal Critical Care Inc., Mallinckrodt Inc., Novartis AG, Valeant Pharmaceuticals, Pfizer Inc., Procter & Gamble Pharmaceuticals, Par Pharmaceutical, Cardinal Health etc.